Terns Pharmaceuticals, Inc. (TERN)
46.96
+2.35
(+5.27%)
USD |
NASDAQ |
Dec 11, 12:39
Terns Pharmaceuticals Research and Development Expense (TTM): 76.99M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Eli Lilly & Co. | 12.56B |
| Pfizer Inc. | 10.13B |
| Altimmune, Inc. | 67.72M |
| Viking Therapeutics, Inc. | 222.48M |
| Rhythm Pharmaceuticals, Inc. | 165.86M |